stockrow
Friday 6 November 2026
Export IMVT’s income statement to Excel — free account
Immunovant, Inc.
IMVT Healthcare Biotechnology
- EPS
- −5.63%
- Free cash flow
- −5.96%
Quarter to June 2026, against a year earlier
30.53
2.14
+7.54%
Follow IMVT
Alert me
Immunovant, Inc. (IMVT) Current ratio
Immunovant, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 7.3×, down 1.8× from fiscal 2026 (9.1×). Over the past ten years it has ranged from 0.9× (fiscal 2018) to 21.8× (fiscal 2021); the current reading is higher than 44% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 9.1× | (18.59%) |
| FY2025 | 11.2× | (18.51%) |
| FY2024 | 13.7× | 46.67% |
| FY2023 | 9.3× | (18.95%) |
| FY2022 | 11.5× | (47.12%) |
| FY2021 | 21.8× | 205.99% |
| FY2020 | 7.1× | 267.34% |
| FY2019 | 1.9× | 126.88% |
| FY2018 | 0.9× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 7.3× | (20.00%) |
| Mar 2026 | 9.1× | (42.27%) |
| Dec 2025 | 15.7× | 73.60% |
| Sep 2025 | 9.1× | (26.41%) |
| 25 more quarters | Free account |
Against its own ten years
Low 0.9×
High 21.8×
Ten-year median
9.3×
Current reading's percentile
44
Current ratio against peers
| Company | Current ratio |
|---|---|
| MANE Veradermics Incorporated compare | 70.5× |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 33.6× |
| CGON CG Oncology, Inc. compare | 22.2× |
| IONS Ionis Pharmaceuticals, Inc. compare | 7.9× |
| IMVT Immunovant, Inc. | 7.3× |
| PTCT PTC Therapeutics, Inc. compare | 3.3× |
| KOD Kodiak Sciences Inc. compare | 2.5× |
| MIRM Mirum Pharmaceuticals, Inc. compare | 2.1× |
| LGND Ligand Pharmaceuticals Incorporated compare | 1.2× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)